Value through Innovation16 January 2013

Boehringer Ingelheim News, Press Releases & Information

Quick access for journalists to the latest news, press releases and articles from Boehringer Ingelheim that cover corporate, research & development, prescription, industrial, animal health and consumer pharmaceutical news.

Latest Press Releases

16.01.2013: U.S. FDA Grants Priority Review to Boehringer Ingelheim’s Afatinib* NDA for EGFR Mutation-Positive Advanced NSCLC
-
For NON-U.S. Media Only
07.01.2013: Boehringer Ingelheim and Eli Lilly and Company announce positive top-line pivotal Phase III data results for empagliflozin
-
EX US & UK. Medical Media Only.
07.01.2013: Lilly reassumes sole worldwide development and commercialization rights for novel basal insulin analog
11.12.2012: Boehringer Ingelheim receives EU approval for Metacam® for the relief of pain following dehorning in calves
11.12.2012: Boehringer Ingelheim discontinues Phase II trial in patients with artificial heart valves
-
For Non-US, Non-UK & Non-Canadian Media Only

Further Press Releases

News Topics: Latest news & press releases, information, images, videos and additional resources

Page content

Boehringer Ingelheim News, Press Releases & Information

Latest Press Releases

Corporate Topics

boehringer-ingelheim.com

Research & Development

Acute Ischaemic Stroke

Cancer

Cardiovascular Disease

COPD

Diabetes

HIV / AIDS

Hypertension

Parkinson’s Disease

Restless Legs Syndrome

Stroke Prevention in AF

Venous Thromboembolism

Global Media pool

Media Contact

Boehringer Ingelheim

Further Media Channels

Other News & Press Releases